Paras Healthcare Limited (NSE:PARASHLTH)
India · Delayed Price · Currency is INR 693.00
0.00 (0.00%)
At close: Oct 27, 2026
Paras Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue | 16,060 | 12,941 | 11,290 | 9,179 | 7,799 |
Revenue Growth | 24.10% | 14.62% | 23.00% | 17.69% | 30.34% |
Cost of Revenue | 6,589 | 5,430 | 4,910 | 3,922 | 3,260 |
Gross Profit | 9,471 | 7,511 | 6,381 | 5,257 | 4,539 |
Selling, General & Admin | 693.91 | 613.7 | 580.09 | 318.01 | 301.71 |
Other Operating Expenses | 1,691 | 1,944 | 1,668 | 3,713 | 3,543 |
Operating Expenses | 3,820 | 3,714 | 3,056 | 4,686 | 4,359 |
Operating Income | 5,651 | 3,797 | 3,325 | 571.51 | 179.91 |
Interest Expense | -1,150 | -876.46 | -647.54 | -491.89 | -315.22 |
Interest & Investment Income | 180.34 | 142.55 | 138.86 | 77.85 | 89.04 |
Currency Exchange Gain (Loss) | -17.71 | 0.74 | -1.87 | - | - |
Other Non Operating Income (Expenses) | -3,904 | -3,567 | -2,762 | -431.72 | 38.72 |
EBT Excluding Unusual Items | 759.28 | -502.53 | 52.27 | -274.25 | -7.55 |
Gain (Loss) on Sale of Assets | 1.05 | -0.34 | 2.71 | 0.82 | 1.36 |
Other Unusual Items | - | 2.51 | 11.32 | 2.79 | 34.31 |
Pretax Income | 760.33 | -500.36 | 66.3 | -270.64 | 28.12 |
Income Tax Expense | 321.99 | 79.47 | 219.61 | 157.28 | 176.2 |
Earnings From Continuing Operations | 438.34 | -579.83 | -153.31 | -427.92 | -148.08 |
Net Income | 438.34 | -579.83 | -153.31 | -427.92 | -148.08 |
Net Income to Common | 438.34 | -579.83 | -153.31 | -427.92 | -148.08 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 101 | 98 | 98 | 74 | 74 |
Shares Outstanding (Diluted) | 101 | 98 | 98 | 74 | 74 |
Shares Change | 3.36% | - | 32.77% | - | - |
EPS (Basic) | 4.34 | -5.94 | -1.57 | -5.82 | -2.01 |
EPS (Diluted) | 4.34 | -5.94 | -1.57 | -5.82 | -2.01 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -59.05 | -504.74 | -1,051 | -691.56 | -567.3 |
Free Cash Flow Per Share | -0.58 | -5.17 | -10.77 | -9.41 | -7.72 |
Gross Margin | 58.97% | 58.04% | 56.51% | 57.27% | 58.20% |
Operating Margin | 35.19% | 29.34% | 29.45% | 6.23% | 2.31% |
Profit Margin | 2.73% | -4.48% | -1.36% | -4.66% | -1.90% |
Free Cash Flow Margin | -0.37% | -3.90% | -9.31% | -7.53% | -7.27% |
EBITDA | 6,835 | 4,831 | 4,023 | 1,100 | 595.9 |
EBITDA Margin | 42.56% | 37.33% | 35.63% | 11.98% | 7.64% |
D&A For EBITDA | 1,184 | 1,034 | 697.69 | 528.02 | 415.99 |
EBIT | 5,651 | 3,797 | 3,325 | 571.51 | 179.91 |
EBIT Margin | 35.19% | 29.34% | 29.45% | 6.23% | 2.31% |
Effective Tax Rate | 42.35% | - | 331.24% | - | 626.60% |
Revenue as Reported | 16,288 | 13,142 | 11,510 | 9,361 | 7,932 |